ANUHPHR
Start SIP
Invest Now
Start SIP in ANUHPHR
Performance
- Low
- ₹81
- High
- ₹85
- 52 Week Low
- ₹69
- 52 Week High
- ₹115
- Open Price₹85
- Previous Close₹84
- Volume52,863
- 50 DMA₹78.30
- 100 DMA₹80.93
- 200 DMA₹85.40
Investment Returns
- Over 1 Month + 7.79%
- Over 3 Month + 1.85%
- Over 6 Month -9.16%
- Over 1 Year -10.42%
Smart Investing Starts Here Start SIP with Anuh Pharma for Steady Growth!
Anuh Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 19.9
- PEG Ratio
- -1.2
- Market Cap Cr
- 832
- P/B Ratio
- 2.5
- Average True Range
- 3.19
- EPS
- 4.17
- Dividend Yield
- 1.8
- MACD Signal
- 0.18
- RSI
- 62.81
- MFI
- 56.01
Anuh Pharma Financials
Anuh Pharma Technicals
EMA & SMA
Current Price
₹83.00
-0.6
(-0.72%)
- Bearish Moving Average 0
- Bullish Moving Average 0
- 20 Day
- ₹78.14
- 50 Day
- ₹78.30
- 100 Day
- ₹80.93
- 200 Day
- ₹85.40
Resistance and Support
83.09
- R3 87.13
- R2 85.82
- R1 84.40
- S1 81.67
- S2 80.36
- S3 78.94
Anuh Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-06 | Quarterly Results | |
| 2025-11-07 | Quarterly Results | |
| 2025-08-08 | Quarterly Results & Others | To consider other business matters. per share(30%)Final Dividend |
| 2025-05-23 | Audited Results, Dividend & Bonus issue | |
| 2025-02-07 | Quarterly Results & Others | To consider other business matters. per share(30%)Final Dividend |
Anuh Pharma F&O
About Anuh Pharma
- NSE Symbol
- ANUHPHR
- BSE Symbol
- 506260
- Joint Managing Director
- Mr. Ritesh B Shah
- ISIN
- INE489G01022
Similar Stocks to Anuh Pharma
Anuh Pharma FAQs
Anuh Pharma share price is ₹83 As on 12 February, 2026 | 04:04
The Market Cap of Anuh Pharma is ₹831.9 Cr As on 12 February, 2026 | 04:04
The P/E ratio of Anuh Pharma is 19.9 As on 12 February, 2026 | 04:04
The PB ratio of Anuh Pharma is 2.5 As on 12 February, 2026 | 04:04
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.